MSB 2.67% 96.0¢ mesoblast limited

Ann: Appendix 4C - quarterly, page-61

  1. 3,889 Posts.
    lightbulb Created with Sketch. 1319
    "A lot of comment here that shorters only here to manipulate, but generally for shorters to come in they need to be convinced company is in a fragile position."

    I didn't think they needed that much reason?  Surely it only needs to be a notion that conforms in some way to a set of rules that everyone knows, or maybe just to your own if you have the means?

    Perhaps like;

    "Key worry is cash burn. Cash reserves crucial at this stage of biotech. Over past 6 months close to $50m spend, MSB’s borrowed cash won’t last long at this rate. In weeks cash will be less than debt. Already borrowing at 15% which seems crazy."

    The antidote is to DYOR, but that is beside the point, it reads like a rollicking good story to act on.

 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
96.0¢
Change
0.025(2.67%)
Mkt cap ! $1.096B
Open High Low Value Volume
95.0¢ 96.5¢ 94.0¢ $1.231M 1.291M

Buyers (Bids)

No. Vol. Price($)
4 94461 95.0¢
 

Sellers (Offers)

Price($) Vol. No.
96.0¢ 61151 6
View Market Depth
Last trade - 16.10pm 12/09/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.